Predictive molecular alterations of prostate cancer brain metastases based on a companion diagnostic assay

Key Points

• Molecular alterations were observed in brain metastases of prostate cancer, indicating unique disease progression.
• The study identified specific biomarkers linked to brain metastases, emphasizing their role in prognosis and treatment strategies.
• Assessment using a companion diagnostic assay provided insights into disease characteristics in prostate cancer patients.
• These findings highlight the importance of further investigation into molecular pathways for effective therapeutic interventions.